Best-practice interventions: keeping central line infection at bay.
Hadaway
Lynn C
LC
Lynn Hadaway Associates Inc., Milner, GA, USA.
D000279:Administration, Cutaneous; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage; D019985:Benchmarking; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control; D004866:Equipment Contamination; D004867:Equipment Design; D004868:Equipment Failure; D004869:Equipment Safety; D006801:Humans; D017053:Infection Control / Q000379:methods* / Q000592:standards; D009730:Nursing Assessment; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D017592:Skin Care / Q000379:methods / Q000451:nursing / Q000592:standards
D000891:Anti-Infective Agents, Local; C010882:chlorhexidine gluconate; D002710:Chlorhexidine